AlphAIAlphAI — Financial news for AI agents
stocktitan.net$CCAP

Third-quarter results are due after market close Nov. 9; the webcast follows the next day.

Crescent Capital BDC (CCAP) will release its Q3 2026 financial results on Nov. 9, 2026, after market close. A webcast to discuss the results is scheduled for Nov. 10, 2026, at 12:00 p.m. ET. The company is a business development company focused on middle market investments.

Original reporting
stocktitan.net
Published Oct 30, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CCAP
Neutral
high confidence
Mentioned
$CCAP
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CCAPNeutralLow
01

Why it matters

The announcement primarily informs investors of the timing for the earnings release, with minimal immediate price impact.

02

Market read

Provides a scheduling update for an upcoming earnings release; limited trading relevance until results are disclosed.

03

What to watch

Potential hidden guidance or surprise in the upcoming results could shift sentiment sharply.

Relevance 5/10Novelty 5/10Timing: pre‑market on Nov 9 after close

Background

Crescent Capital BDC (NASDAQ:CCAP) is a business development company that provides capital to middle‑market firms. The press release announces its Q3 2026 earnings call schedule.

Company-level read

Ticker impact

$CCAPNeutralHigh confidence
Context

Crescent Capital BDC announced the date and webcast for its Q3 2026 earnings release.

Expected impact

limited pressure as traders await the actual results; no immediate directional move expected.

Evidence & confidence

Earnings date announcements are routine and typically generate only short‑term positioning rather than a sharp price move.

Market effects

Sector

None significant; the BDC sector may see modest attention around the earnings window.

Regional

US market focus; no broader regional effect.

Global

Limited to investors tracking business development companies.

Counterpoint

What could challenge this read

If the market over‑reacts to the earnings date, a short position could be considered ahead of the actual release.

Key entities

  • company
    Crescent Capital BDC, Inc.

    Business development company issuing the earnings announcement.

Read at source← All news

Related articles

$CCAPHigh

Crescent Capital Q3 2026 slides: earnings beat, $50M buyback unveiled

Crescent Capital BDC (CCAP) reported Q3 2026 earnings of $0.37 per share, beating estimates. The company announced a $50M share buyback and a joint venture to reduce leverage. Shares rose 6.82% in after-hours trading to $9.87, still below NAV. Portfolio assets reached $1.6B, with 91% in senior secured positions. Net investment income declined year-over-year, and NAV per share fell 8%.

investing.com
$CCAPMed

Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.34 Per Share and Announces a $50 Million Share Repurchase Program LOS ANGELES, November 9, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ

SEC EDGAR 8-K
$CCAPMed

Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results; Declares a Third Quarter Base Dividend of $0.34 Per Share LOS ANGELES, August 10, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.36

SEC EDGAR 8-K
$HIMSMedAI 8/10

Hims & Hers Celebrated Its Eli Lilly Deal, Then Lost a Quarter of Its Value in a Week

Hims & Hers (HIMS) shares fell 25.67% last week, despite a deal with Eli Lilly (LLY) announced on November 6. HIMS reported Q3 revenue of $890.37M, up 48.65%, but margins dropped to 57% from 74%. Lilly's Q3 revenue rose 38.61% to $24.397B, and it raised its full-year outlook to $91B-$92B. HIMS's subscriber base shrank by 100,000 to 2.8M, and it cut full-year Adjusted EBITDA guidance to $257M-$277M.

247wallst.com
$ACHRMedAI 8/10

ACHR Stock In Spotlight After Price Target Cuts – Analysts Weigh FAA Progress, Acquisition-Related Revenue Recognition

Archer Aviation (ACHR) saw its price targets lowered by Needham and Cantor Fitzgerald following Q3 results. Needham cut its target to $7 from $9, citing FAA progress and higher cash needs, while Cantor reduced its target to $10 from $11. ACHR reported Q3 revenue of $5.1M, beating estimates, but net loss widened to $274.6M. Seven of nine analysts rate the stock 'Buy' or 'Strong Buy'. ACHR shares traded 5% lower.

finance.yahoo.com